News View all news
CDC testing guidance was published against scientists' objections
CDC scientists neither produced nor supported last month's recommendation playing down the need for COVID-19 testing among individuals who have been exposed to the virus but are asymptomatic, according to sources familiar with the matter and internal documents obtained by the New York Times.
An experimental drug protects COVID-19 patients, Eli Lilly claims
Interim findings from Eli Lilly's ongoing COVID-19 drug trial show great promise for the study intervention, a monoclonal antibody produced from the plasma of recovered patients. Among more than 450 newly diagnosed cases of infection, the test drug markedly lowered levels of the virus and curbed symptoms.
Hospitals failed to fully contain COVID-19 inside their walls
According to previously unpublished data provided by CDC, thousands of inpatients contracted COVID-19 between May and June while hospitalized for other reasons. One-half of all U.S. hospitals voluntarily reported data on institution-acquired infections over the 9-week period.
Eli Lilly arthritis drug helped hospitalized COVID-19 patients recover faster
Backed by clinical trial data, Eli Lilly and Incyte Corp. will pursue emergency use authorization for their rheumatoid arthritis drug baricitinib (Olumiant) as a treatment for COVID-19. Previous research has demonstrated that certain steroids, owing to their anti-inflammatory properties, may benefit infected patients.
September 3, 2020
During this Pandemic, It’s Time to Expand Children’s Access to…
My op-ed that follows first appeared on September 2, 2020, edition of Morning Consult. I’m sharing it in this space to highlight how APhA keeps fighting for pharmacists and their patients during the…0 comments
September 14, 2020
APhA Names Antonio Ciaccia Senior Advisor for Disruptive Innovation and Practice Transformation
The American Pharmacists Association (APhA) announced today that it has named Antonio Ciaccia, Chief Strategy Officer of 3 Axis Advisors, as APhA’s Senior Advisor for Disruptive Innovation and Practice Transformation. This addition will supercharge the association’s efforts to disrupt our broken payment models and drive the profession of pharmacy forward. Antonio begins his duties immediately.
September 14, 2020
APhA Names Dr. Rafael Saenz Chief of Staff
The American Pharmacists Association (APhA) announced today that it has named Rafael Saenz, PharmD, MS, FASHP, as Chief of Staff of the association. Dr. Saenz will have oversight for membership and member relations, health systems and international strategy, meetings and expositions, publications and periodicals, communications and marketing, and creative services.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.